Discover 1,803 paid clinical trials in Greensboro, North Carolina. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Filter
2
Filter results
Results: 1,803
Phase III Study to Assess the Safety and Efficacy of SL1002 for Osteoarthritis Knee Pain
for
Osteoarthritis Knee Pain
Location: Winston-Salem NC, Charlotte NC, Richmond VA,
Sponsor: Saol Therapeutics Inc
Sex: All
Age: 40+
Code: NCT07226258
Phase3, Recruiting
A Prospective Trial to Identify Biomarkers Involved in the Transition From Acute to Persistent Chronic Low Back Pain
for
Acute Low Back Pain, Chronic Low Back Pain
Location: Winston-Salem NC
Sponsor: University of Parma
Sex: All
Age: 18 - 70+
Code: NCT02037763
Recruiting
A Study of MF101 in Postmenopausal Women
for
Hot Flushes, Vasomotor Symptoms
Location: Winston-Salem NC, Raleigh NC, Charlottesville VA,
Sponsor: Bionovo
Sex: Female
Age: 40 - 65
Code: NCT00906308
Phase3, Recruiting
Evaluating a New Program for Successfully Coping With Adversity
Location: Greensboro NC, Cary NC, Wake Forest NC, Hickory NC,
Sponsor: Adverum Biotechnologies, Inc.
Sex: All
Age: 50+
Code: NCT07482176
Phase3, Recruiting
Active & Responsive
Oxygen Toxicity: Mechanisms in Humans
for
Oxygen Toxicity, Hypercapnia, Seizures
Location: Durham NC
Sponsor: Duke University
Sex: All
Age: 18 - 45
Code: NCT05761756
Recruiting
Active & Responsive
A Study of YL201 in Patients With Advanced Solid Tumors
for
Advanced Solid Tumor
Location: Chapel Hill NC, Fairfax VA, Washington D.C. DC,
Sponsor: MediLink Therapeutics (Suzhou) Co., Ltd.
Sex: All
Age: 18+
Code: NCT05434234
Phase1, Phase2, Recruiting
Featured
A Study to Assess Adverse Events and Change in Disease Activity in Participants 12 Years of Age or Older With Locally Advanced or Metastatic Solid Tumors That Harbor MET Amplification Receiving Intravenously Infused Telisotuzumab Adizutecan
for
Solid Tumors Harboring MET Amplification
Location: Durham NC, Fairfax VA, Nashville TN, New York NY,
Sponsor: AbbVie
Sex: All
Age: 12+
Code: NCT07196644
Phase2, Recruiting
Featured
Study to Assess Adverse Events and Pharmacokinetics in Adult Participants With Non-Small Cell Lung Cancer, Head and Neck Squamous Cell Carcinoma and Other Solid Tumors, Receiving Intravenous Infusion of Azirkitug Alone or in Combination(s) With Budigalimab, Bevacizumab, or Telisotuzumab Adizutecan
for
Non-Small Cell Lung Cancer,
Location: Durham NC, Huntersville NC, Fairfax VA, Louisville KY,
Sponsor: AbbVie
Sex: All
Age: 18+
Code: NCT05005403
Phase1, Recruiting
Featured
A Study to Assess A Change in Disease Activity and Adverse Events of Intravenous Etentamig and Daratumumab (Etentamig+D) Compared to Daratumumab, Lenalidomide, and Dexamethasone (DRd) in Adult Participants With Newly Diagnosed Multiple Myeloma Not Eligible for Transplant
for
Multiple Myeloma
Location: Chapel Hill NC, Roanoke VA, Fairfax VA, Atlanta GA,
Sponsor: AbbVie
Sex: All
Age: 18+
Code: NCT07095452
Phase2, Phase3, Recruiting
Featured
Crohn's Disease: Efficacy, Safety, and Pharmacokinetics of Upadacitinib in Pediatric Subjects With Moderately to Severely Active Crohn's Disease
for
Crohn's Disease
Location: Chapel Hill NC, Philadelphia PA, Cleveland OH,